Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations

Publications

  1. 2009
  2. [10 years of the Working Group for Geriatric Oncology of the DGHO/DGG/AIO]

    Bokemeyer, C., 2009, In: ONKOLOGIE. 32, 3, p. 2 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Adjuvante Therapie des Kolonkarzinoms

    Schuch, G., Arnold, D. & Bokemeyer, C., 2009, In: ONKOLOGE. 15, p. 1215-1222

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.

    Ychou, M., Hohenberger, W., Thezenas, S., Navarro, M., Maurel, J., Bokemeyer, C., Shacham-Shmueli, E., Rivera, F., Kwok-Keung Choi, C. & Santoro, A., 2009, In: ANN ONCOL. 20, 12, p. 1964-1970 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases.

    Stang, A., Fischbach, R., Teichmann, W., Bokemeyer, C. & Braumann, D., 2009, In: EUR J CANCER. 45, 10, p. 1748-1756 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.

    Atanackovic, D., Hildebrandt, Y., Jadczak, A., Cao, Y., Luetkens, T., Meyer, S., Kobold, S., Bartels, K., Pabst, C., Lajmi, N., Gordic, M., Stahl, T., Zander, A. R., Bokemeyer, C. & Kröger, N., 2009, In: HAEMATOLOGICA. *95*, 5, p. 785-793 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Catumaxomab - Antikörper-basierte intraperitoneale Therapie bei malignem Aszites

    Bokemeyer, C. & Schuch, G., 2009, In: Arzneimittelther. 9, p. 264-270

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Chemotherapie-induzierte Kardiotoxizität

    Oechsle, K. & Bokemeyer, C., 2009, Supportivtherapie in der Onkologie. Urban & Vogel, p. 62-71 10 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  9. Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level <10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.

    Vansteenkiste, J., Hedenus, M., Gascon, P., Bokemeyer, C., Ludwig, H., Vermorken, J., Hamilton, L., Bridges, K. & Pujol, B., 2009, In: BMC CANCER. 9, p. 311

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Decrease of CD4(+)FOXP3(+) T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor.

    Freier, E., Weber, C. S., Nowottne, U., Horn, C., Bartels, K., Meyer, S., Hildebrandt, Y., Luetkens, T., Cao, Y., Pabst, C., Muzzulini, J., Schnee, B., Brunner-Weinzierl, M. C., Marangolo, M., Bokemeyer, C., Deter, H-C. & Atanackovic, D., 2009, In: PSYCHONEUROENDOCRINO.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

    Schafhausen, P., Dierlamm, J., Bokemeyer, C., Brümmendorf, T., Bacher, U., Zander, A. R., Schnittger, S. & Hochhaus, A., 2009, In: CANCER GENET-NY. 189, 1, p. 63-67 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases.

    Thoem, I., Schult-Kronefeld, O., Burkholder, I., Schuch, G., Andritzky, B., Kastendieck, H., Edler, L., Wagener, C., Bokemeyer, C., Schumacher, U. & Laack, H-E., 2009, In: ANTICANCER RES. 29, 1, p. 249-254 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.

    Bokemeyer, C., Bondarenko, I., Makhson, A., Hartmann, J. T., Aparicio, J., de Braud, F., Donea, S., Ludwig, H., Schuch, G., Stroh, C., Loos, A. H., Zubel, A. & Koralewski, P., 2009, In: J CLIN ONCOL. 27, 5, p. 663-671 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.

    Oechsle, K., Bokemeyer, C., Hartmann, J. T., Budach, W., Trarbach, T., Stahl, M., Boehlke, I. & Kollmannsberger, C., 2009, In: J CANCER RES CLIN. 135, 2, p. 163-172 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Gene amplification in ductal carcinoma in situ of the breast.

    Burkhardt, L., Grob, T., Hermann, I., Burandt, E. C., Choschzick, M., Jänicke, F., Müller, V., Bokemeyer, C., Simon, R., Sauter, G., Wilczak, W. & Lebeau, A., 2009, In: BREAST CANCER RES TR.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. HER-2 amplification is highly homogenous in gastric cancer.

    Marx, A., Tharun, L., Muth, J., Dancau, A. M., Simon, R., Yekebas, E. F., Kaifi, J., Mirlacher, M., Brümmendorf, T., Bokemeyer, C., Izbicki, J. R. & Sauter, G., 2009, In: HUM PATHOL. 40, 6, p. 769-777 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. HER-2/neu analysis in breast cancer bone metastases.

    Zustin, J., Boddin, K., Tsourlakis, M. C., Burandt, E. C., Mirlacher, M., Jänicke, F., Izbicki, J. R., Rüther, W., Rueger, J. M., Bokemeyer, C., Simon, R. & Sauter, G., 2009, In: J CLIN PATHOL. 62, 6, p. 542-546 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.

    Lorch, A., Neubauer, A., Hackenthal, M., Dieing, A., Hartmann, J. T., Rick, O., Bokemeyer, C. & Beyer, J., 2009, In: ANN ONCOL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. High-dose chemotherapy in nonseminomatous germ cell cancer.

    Kollmannsberger, C., Beyer, J. & Bokemeyer, C., 2009, In: BJU INT. 104, 9, p. 1398-1403 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. [Improving care in haemophilia treatment: development of a computerized registry]

    Holstein, K., Holstein, F., Bokemeyer, C. & Eifrig, B., 2009, In: HAMOSTASEOLOGIE. 29, 1, p. 27-28 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

    Kobold, S., Hegewisch-Becker, S., Oechsle, K., Jordan, K., Bokemeyer, C. & Atanackovic, D., 2009, In: ONCOLOGIST. 14, 12, p. 1242-1251 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Kardiotoxizitäten bei Chemo-Radiotherapie

    Oechsle, K. & Bokemeyer, C., 2009, In: ONKOLOGE. 15, p. 157-162

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

    Atanackovic, D., Luetkens, T., Hildebrandt, Y., Arfsten, J., Bartels, K., Horn, C., Stahl, T., Cao, Y., Zander, A. R., Bokemeyer, C. & Kröger, N., 2009, In: CLIN CANCER RES. 15, 4, p. 1343-1352 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.

    Honecker, F., Wermann, H., Mayer, F., Gillis, A. J. M., Stoop, H., Gurp, V., Oechsle, K., Oechsle, K., Steyerberg, E., Hartmann, J. T., Dinjens, W. N. M., Bokemeyer, C., Bokemeyer, C. & Looijenga, L. H. J., 2009, In: J CLIN ONCOL. 27, 13, p. 2129-2136 13.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study.

    Aapro, M., Ludwig, H., Bokemeyer, C., MacDonald, K., Soubeyran, P., Turner, M., Albrecht, T. & Abraham, I., 2009, In: ANN ONCOL. 20, 10, p. 1714-1721 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer.

    Schittenhelm, M. M., Kollmannsberger, C., Oechsle, K., Harlow, A., Morich, J., Honecker, F., Kurek, R., Störkel, S., Kanz, L., Corless, C. L., Wong, K-K., Bokemeyer, C. & Heinrich, M. C., 2009, In: MOL CANCER THER. 8, 3, p. 481-489 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.

    Gnjatic, S., Cao, Y., Reichelt, U., Yekebas, E. F., Nölker, C., Marx, A., Erbersdobler, A., Nishikawa, H., Hildebrandt, Y., Bartels, K., Horn, C., Stahl, T., Gout, I., Filonenko, V., Ling, K-L., Cerundolo, V., Luetkens, T., Ritter, G., Friedrichs, K., Leuwer, R., Hegewisch-Becker, S., Izbicki, J. R., Bokemeyer, C., Old, L. J. & Atanackovic, D., 2009, In: INT J CANCER.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.

    Choschzick, M., Lebeau, A., Marx, A., Tharun, L., Terracciano, L., Heilenkötter, U., Jänicke, F., Bokemeyer, C., Simon, R., Sauter, G. & Schwarz, J., 2009, In: HUM PATHOL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie.

    Goekkurt, E., Al-Batran, S-E., Hartmann, J. T., Mogck, U., Schuch, G., Kramer, M., Jaeger, E., Bokemeyer, C., Ehninger, G. & Stoehlmacher, J., 2009, In: J CLIN ONCOL. 27, 17, p. 2863-2873 17.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

    Schilling, G., Bruweleit, M., Harbeck, N., Thomssen, C., Becker, K., Hoffmann, R., Villena, C., Schütte, M., Hossfeld, D., Bokemeyer, C. & De Wit, M., 2009, In: INVEST NEW DRUG. 27, 2, p. 166-172 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Primary NK/T cell lymphoma nasal type of the stomach with skin involvement: a case report

    Kobold, S., Merz, H., Tiemann, M., Mahuad, C., Bokemeyer, C., Koop, I. & Fiedler, W., 2009, In: RARE TUMORS. 1, 2, p. 173-175 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Eric, V. C., Labianca, R., Bodoky, G., Barone, C., Aranda, E., Nordlinger, B., Topham, C., Tabernero, J., André, T., Sobrero, A. F., Mini, E., Greil, R., Francesco, D. C., Collette, L., Cisar, L., Zhang, X., Khayat, D., Bokemeyer, C., Roth, A. D. & Cunningham, D., 2009, In: J CLIN ONCOL. 27, 19, p. 3117-3125 19.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. [Registries and clinical trials in geriatric oncology in Germany]

    Honecker, F. & Bokemeyer, C., 2009, In: ONKOLOGIE. 32, 3, p. 14-18 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. [Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors]

    Lorch, A., Oechsle, K., Bokemeyer, C. & Beyer, J., 2009, In: UROLOGE. 48, 4, p. 364-371 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Severe aplastic anaemia following leflunomide therapy.

    Wüsthof, M., Smirnova, A., Bacher, U., Kröger, N., Zander, A. R., Schuch, G. & Bokemeyer, C., 2009, In: RHEUMATOLOGY.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 years.

    Thoem, I., Rogers, C., Andritzky, B., Witzel, I., Schuch, G., Hossfeld, D. K., Bokemeyer, C. & Laack, E., 2009, In: ONKOLOGIE. 32, 12, p. 741-746 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. [Stage-specific treatment for testicular germ cell tumours]

    Heidenreich, A., Bokemeyer, C. & Souchon, R., 2009, In: UROLOGE. 48, 4, p. 377-385 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis.

    Schultze, A., Decker, S., Wellbrock, J., Horst, A., Vohwinkel, G., Schuch, G., Bokemeyer, C., Loges, S. & Fiedler, W., 2009, In: INVEST NEW DRUG.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Therapie des metastasierten Kolonkarzinoms

    Folprecht, G., Bokemeyer, C. & Weitz, J., 2009, In: ONKOLOGE. 15, p. 1223-1234

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.

    Murga-Penas, E-M., Maria, E., Callet-Bauchu, E., Ye, H., Gazzo, S., Schilling, G., Schilling, G., Vettorazzi, E., Vettorazzi, E., Salles, G., Wlodarska, I., Bokemeyer, C., Dierlamm, J. & Dierlamm, J., 2009, In: BLOOD.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Thromboembolische Komplikationen - Prophylaxe und Therapie im Fokus

    Langer, F., Holstein, K., Eifrig, B. & Bokemeyer, C., 2009, In: ONKOLOGE. 15, p. 150-156

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.

    Haubold, K., Rink, M., Spath, B., Friedrich, M., Chun, F., Marx, G., Amirkhosravi, A., Francis, J. L., Bokemeyer, C., Eifrig, B. & Langer, F., 2009, In: THROMB HAEMOSTASIS. 101, 6, p. 1147-1155 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.

    Ludwig, H., Aapro, M., Bokemeyer, C., Macdonald, K., Soubeyran, P., Turner, M., Albrecht, T. & Abraham, I., 2009, In: EUR J CANCER. 45, 9, p. 1603-1615 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. 2008
  45. [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial.

    De Wit, M., Brenner, W., Hartmann, M., Kotzerke, J., Hellwig, D., Lehmann, J., Franzius, C., Kliesch, S., Schlemmer, M., Tatsch, K., Heicappell, R., Geworski, L., Amthauer, H., Dohmen, B. M., Schirrmeister, H., Cremerius, U., Bokemeyer, C. & Bares, R., 2008, In: ANN ONCOL. 19, 9, p. 1619-1623 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.

    Oechsle, K., Hartmann, M., Brenner, W., Venz, S., Weissbach, L., Franzius, C., Kliesch, S., Mueller, S., Krege, S., Heicappell, R., Bares, R., Bokemeyer, C. & De Wit, M., 2008, In: J CLIN ONCOL. 26, 36, p. 5930-5935 36.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).

    Görn, M., Habermann, C., Anige, M., Thoem, I., Schuch, G., Andritzky, B., Brandl, S., Burkholder, I., Edler, L., Hossfeld, D., Bokemeyer, C. & Laack, H-E., 2008, In: ONKOLOGIE. 31, 4, p. 185-189 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?

    Bokemeyer, C., 2008, In: J CLIN ONCOL. 26, 11, p. 1783-1785 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.

    Wellbrock, J., Schultze, A., Schafhausen, P., Otterstetter, S., Dierlamm, J., Bokemeyer, C., Brümmendorf, T., Fiedler, W. & Loges, S., 2008, In: BRIT J HAEMATOL. 142, 1, p. 115-118 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.

    Atanackovic, D., Altorki, N. K., Cao, Y., Ritter, E., Ferrara, C. A., Ritter, G., Hoffman, E. W., Bokemeyer, C., Old, L. J. & Gnjatic, S., 2008, In: P NATL ACAD SCI USA. 105, 5, p. 1650-1655 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

    Atanackovic, D., Cao, Y., Luetkens, T., Panse, J., Faltz, C., Arfsten, J., Bartels, K., Wolschke, C., Eiermann, T., Zander, A. R., Fehse, B., Bokemeyer, C. & Kröger, N., 2008, In: HAEMATOLOGICA. 93, 3, p. 423-430 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy.

    Oechsle, K., Kollmannsberger, C., Honecker, F., Boehlke, I. & Bokemeyer, C., 2008, In: EUR J CANCER. 44, 12, p. 1663-1669 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review